OAK

Identification and toxicity prediction of metribuzin transformation products in activated sludge using suspect and nontarget screening

Metadata Downloads
Author(s)
Kim, HyewonChoi, YeowoolKim, Young MoJeon, JunhoKim, Sang Don
Type
Article
Citation
Ecotoxicology and Environmental Safety, v.321
Issued Date
2026-08
Abstract
Pesticides entering wastewater treatment plants (WWTPs) are often only partially degraded and can be transformed into various transformation products (TPs) through processes such as microbial degradation. This study focused on metribuzin, a widely used selective herbicide that is particularly toxic to freshwater algae and frequently reaches aquatic environments through rural WWTP effluent. To better understand its fate, we investigated metribuzin's transformation behavior in an activated-sludge system, aiming to identify its TPs and evaluate their potential toxicity to aquatic organisms. Biotransformation experiments were performed in activated-sludge-seeded batch reactors over 16 days. Suspect and nontarget screening using liquid chromatography-high-resolution mass spectrometry enabled TP identification, while the ECOSAR model was used to estimate aquatic toxicity. A total of 10 TPs were detected, and a transformation pathway was proposed. Among them, metribuzin-desamino and metribuzin-diketo were the major products. Several TPs were predicted to be more toxic than the parent compound, and all retained metribuzin's toxicophore, indicating a similar mode of action and potentially greater toxicological risk. Given that metribuzin and its TPs can coexist with other organic pollutants in WWTP effluents and may exert combined toxic effects on aquatic life, these findings underscore the importance of managing not only the parent compound but also its TPs in wastewater treatment systems.
Publisher
Academic Press
ISSN
0147-6513
DOI
10.1016/j.ecoenv.2026.120450
URI
https://scholar.gist.ac.kr/handle/local/34358
공개 및 라이선스
  • 공개 구분공개
파일 목록
  • 관련 파일이 존재하지 않습니다.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.